04 Oct 2020

PENUMBRA OFFERS INDIGO LIGHTNING 12 AS BASIS FOR U.S. FRANCHISE GROWTH

  Penumbra Inc. has announced its next phase for vascular franchise growth with U.S. commercial availability of the Indigo System Lightning 12 and the appointments of Corey L. Teigen, MD, to chief scientific officer; and James F. Benenati, MD, FSIR, to chief medical officer – two newly created positions. Innovating the

0